American Biogenetic, Abbott deal

Abbott received a worldwide license for MABXA's Thrombus Precursor Protein ( TpP) immunoassay, a blood test for the early detection of impending heart attacks and other cardiovascular disorders. Abbott will make up-front and milestone payments, and MABXA will supply reagents. ...